Currently out of the existing stock ratings of Eric Le Berrigaud, 9 are a HOLD (27.27%), 24 are a BUY (72.73%).

Eric Le Berrigaud

Work Performance Price Targets & Ratings Chart

Analyst Eric Le Berrigaud, currently employed at STIFEL, carries an average stock price target met ratio of 57.14% that have a potential upside of 12.38% achieved within 279 days. Previously, Eric Le Berrigaud worked at BRYAN GARNIER.

Eric Le Berrigaud’s has documented 56 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on NVO, Novo Nordisk A/S at 28-Dec-2024.

Wall Street Analyst Eric Le Berrigaud

Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 2/28/2022. The price target of $53.34 was fulfilled within 32 days with a profit of $5.14 (10.66%) receiving and performance score of 3.33.

Average potential price target upside

of $55.62 (16.86%) on RH (RH).
of $29.35 (24.38%) on AZN (ASTRAZENECA PLC ADR).
of $25.03 (30.83%) on NVS (NOVARTIS AG ADR).

SNY Sanofi ADR NVS Novartis AG ADR AZN AstraZeneca PLC ADR GSK GlaxoSmithKline PLC ADR NVO Novo Nordisk A/S RHHBY Roche Holding Ltd ADR IP International Paper RH RH

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Mark Purcell (MORGAN STANLEY)